|Mr. Michael Sammells||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Mark Briscoe||Gen. Mang. of Operations||N/A||N/A||N/A|
|Mr. David Shirer||Gen. Mang. of Investor Relations||N/A||N/A||N/A|
|Ms. Ingrid A. Player||Group Exec. of Legal, Governance & Sustainability, Gen. Counsel and Sec.||N/A||N/A||1973|
|Ms. Cathy Jones||National Mang. of Quality & Compliance||N/A||N/A||N/A|
Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia. As of June 6, 2019, Healthscope Limited was taken private.
Healthscope Limited’s ISS Governance QualityScore as of April 1, 2019 is 5. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 6; Compensation: 8.